Despite hype, evidence does not support cannabis replacing opioids for pain
Despite strong preclinical evidence and public advocacy, controlled human studies and clinical trials do not support robust analgesic or opioid-sparing effects from cannabis/cannabinoid combinations for treating chronic pain or opioid use disorder.
Quick Facts
What This Study Found
Preclinical studies show cannabinoids enhance opioid analgesia and reduce required opioid doses in animals. However, controlled human studies and clinical trials have not demonstrated robust analgesic or opioid-sparing effects. Meta-analyses do not strongly support cannabinoids for chronic pain. There may be a modest signal for THC suppressing some opioid withdrawal symptoms, but not complete amelioration. Despite anecdotal and correlational reports, no strong data support cannabis reducing opioid overdose.
Key Numbers
No specific pooled statistics. Review synthesized preclinical, clinical trial, and meta-analytic evidence.
How They Did This
Review of preclinical evidence, controlled human laboratory studies, clinical trials, and meta-analyses examining opioid/cannabinoid combinations for pain and opioid use disorder.
Why This Research Matters
Public advocacy for cannabis as an opioid replacement is widespread, but the disconnect between preclinical promise and clinical reality could lead to harmful policy decisions if not clearly communicated.
The Bigger Picture
The gap between animal data and human data for opioid-cannabinoid interactions is one of the most important and underappreciated aspects of the cannabis-for-pain debate.
What This Study Doesn't Tell Us
Narrative review structure. Human studies may use different doses, formulations, and outcomes than optimal. Some animal-to-human translational failure may reflect methodological issues rather than true lack of effect.
Questions This Raises
- ?Why do preclinical opioid-sparing effects not translate to humans?
- ?Would different cannabis formulations or dosing strategies produce better human results?
Trust & Context
- Key Stat:
- Human studies do not confirm opioid-sparing effects
- Evidence Grade:
- Comprehensive review integrating preclinical and clinical evidence, including meta-analyses.
- Study Age:
- 2020 review.
- Original Title:
- Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence.
- Published In:
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 36, 206-216 (2020)
- Authors:
- Babalonis, Shanna(8), Walsh, Sharon L(4)
- Database ID:
- RTHC-02404
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Can cannabis replace opioids for pain?
Despite public advocacy and strong animal data, controlled human studies and clinical trials have not demonstrated that cannabis produces robust pain relief or reduces the need for opioid doses in chronic pain patients.
Does cannabis help with opioid withdrawal?
There may be a modest signal that THC can suppress some opioid withdrawal symptoms, but it does not completely address withdrawal and there are safety concerns about using THC during the heightened physiological stress of withdrawal.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- thc-and-painkillers-opioid-interactions
- thc-and-muscle-relaxers-combining
- thc-and-ibuprofen-safe-combine-research
Cite This Study
https://rethinkthc.com/research/RTHC-02404APA
Babalonis, Shanna; Walsh, Sharon L. (2020). Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 36, 206-216. https://doi.org/10.1016/j.euroneuro.2020.03.002
MLA
Babalonis, Shanna, et al. "Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence.." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2020. https://doi.org/10.1016/j.euroneuro.2020.03.002
RethinkTHC
RethinkTHC Research Database. "Therapeutic potential of opioid/cannabinoid combinations in ..." RTHC-02404. Retrieved from https://rethinkthc.com/research/babalonis-2020-therapeutic-potential-of-opioidcannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.